Lipid Nanoparticle Technology for Clinical Translation of siRNA Therapeutics

Volume: 52, Issue: 9, Pages: 2435 - 2444
Published: Aug 9, 2019
Abstract
Delivering nucleic acid-based therapeutics to cells is an attractive approach to target the genetic cause of various diseases. In contrast to conventional small molecule drugs that target gene products (i.e., proteins), genetic drugs induce therapeutic effects by modulating gene expression. Gene silencing, the process whereby protein production is prevented by neutralizing its mRNA template, is a potent strategy to induce therapeutic effects in...
Paper Details
Title
Lipid Nanoparticle Technology for Clinical Translation of siRNA Therapeutics
Published Date
Aug 9, 2019
Volume
52
Issue
9
Pages
2435 - 2444
Citation AnalysisPro
  • Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
  • Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.